Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Michele G. Sullivan

    News

    Chlamydia infections associated with more than a doubling of ovarian cancer risk

    Author:
    Michele G. Sullivan
    Publish date: March 16, 2018

    The presence of an antibody to chlamydia increased the chance of ovarian cancer by up to 2.25-fold in case-control studies in Poland and the U.S...

    • Read More

    News

    Variants in one gene account for 7% of juvenile myoclonic epilepsy cases

    Author:
    Michele G. Sullivan
    Publish date: March 14, 2018

    Twenty-one separate variants in the ICK gene accounted for the cases.

    • Read More

    News

    Tenofovir didn’t prevent hepatitis B transmission to newborns

    Author:
    Michele G. Sullivan
    Publish date: March 7, 2018

    The maternal HBV transmission rate was unexpectedly low in both the placebo and active groups.

    • Read More

    News

    Treat to target in RA: Finding the right path forward

    Author:
    Michele G. Sullivan
    Publish date: March 7, 2018

    Challenges include making it as easy as possible for clinicians to do and motivating patients to engage fully with treatment.

    • Read More

    News

    Here are the ‘must-see’ sessions at HM18

    Author:
    Michele G. Sullivan
    Publish date: March 1, 2018

    New tracks on managing alternative providers, palliative care offered.

    • Read More

    News

    Could guselkumab be a disease-modifying agent in plaque psoriasis?

    Author:
    Michele G. Sullivan
    Publish date: February 25, 2018

    SAN DIEGO – Questions remain about why some patients maintain durable response.

    • Read More

    News

    Ustekinumab quells aortic inflammation in patients with severe psoriasis

    Author:
    Michele G. Sullivan
    Publish date: February 24, 2018

    SAN DIEGO – The benefit may be a class-associated effect.

    • Read More

    News

    Dual kinase inhibitor performs well in its first safety, efficacy study for atopic dermatitis

    Author:
    Michele G. Sullivan
    Publish date: February 24, 2018

    SAN DIEGO – The novel molecule, ASN002, inhibits Janus kinase and spleen tyrosine kinase.

    • Read More

    News

    Upadacitinib calms itch, clears skin in moderate to severe atopic dermatitis

    Author:
    Michele G. Sullivan
    Publish date: February 21, 2018

    Almost 60% of those taking 30 mg of the JAK1-selective inhibitor experienced 90% skin clearance in the phase 2b study.

    • Read More

    News

    Risankizumab outpaced ustekinumab for complete clearance of plaque psoriasis

    Author:
    Michele G. Sullivan
    Publish date: February 19, 2018

    Nearly 60% of those taking the investigational drug had cleared all lesions after 52 weeks of treatment.

    • Read More

    Video

    VIDEO: Gene test guides need for sentinel node biopsy in elderly melanoma patients

    Author:
    Michele G. Sullivan
    Publish date: February 18, 2018

    With T1-T2 tumors and a Class 1A test result, SLN positivity was 1.6% in patients 65 years and older.

    • Read More

    News

    Short cervical length more common among black women, and more predictive of preterm birth

    Author:
    Michele G. Sullivan
    Publish date: February 15, 2018

    DALLAS – Findings from Washington University, St. Louis, may help explain the consistently higher rates of spontaneous preterm birth among black...

    • Read More

    News

    Multigene test panel helps diagnose fetal skeletal abnormalities

    Author:
    Michele G. Sullivan
    Publish date: February 15, 2018

    DALLAS – A multigene skeletal dysplasia panel correctly predicted fetal lethality or viability in 75% of positive samples.

    • Read More

    News

    Abdominal CT refines treatment in refractory puerperal fever

    Author:
    Michele G. Sullivan
    Publish date: February 13, 2018

    DALLAS – A 10-year retrospective review at one medical center looked for treatment changes due to CT results.

    • Read More

    News

    Intrapartum maternal oxygen may not be beneficial for resuscitating fetuses with category II heart tracings

    Author:
    Michele G. Sullivan
    Publish date: February 13, 2018

    DALLAS – A clinical trial is the first step in challenging the widely accepted practice of automatic maternal oxygen.

    • Read More

    Pages

    • « first
    • …
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery